Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Income from Continuing Operations (2022 - 2026)

Envoy Medical's Income from Continuing Operations history spans 5 years, with the latest figure at 5959000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 6.37% to 5959000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 24217000.0, a 16.68% decrease, with the full-year FY2025 number at 23860000.0, down 18.87% from a year prior.
  • Income from Continuing Operations hit 5959000.0 in Q1 2026 for Envoy Medical, up from 6385000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for COCH hit a ceiling of 12461381.0 in Q1 2022 and a floor of 6723000.0 in Q4 2023.
  • Historically, Income from Continuing Operations has averaged 2403585.47 across 5 years, with a median of 4933000.0 in 2024.
  • The widest YoY moves for Income from Continuing Operations: up 26.63% in 2024, down 785.52% in 2024.
  • Tracing COCH's Income from Continuing Operations over 5 years: stood at 1682859.0 in 2022, then plummeted by 299.5% to 6723000.0 in 2023, then rose by 26.63% to 4933000.0 in 2024, then fell by 29.43% to 6385000.0 in 2025, then grew by 6.67% to 5959000.0 in 2026.
  • Business Quant data shows Income from Continuing Operations for COCH at 5959000.0 in Q1 2026, 6385000.0 in Q4 2025, and 6179000.0 in Q3 2025.